Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Lenus eHealth ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmarkIFRS Analyst: XBRLDenmarkIFRS

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.8% 1.8%   Bankruptcy risk   5.6% 1.5% 2.2% 2.4% 3.3% 2.8% 3.7% 3.6%   Credit score (0-100)   42 77 66 62 54 58 52 53   Credit rating   BBB A BBB BBB BBB BBB BBB BBB   Credit limit (kDKK)   0.0 30.7 1.0 3.1 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 18,575 53,577 131,533 23,652 26,486 26,486 26,486   Gross profit   0.0 15,225 39,336 59,249 4,859 9,966 0.0 0.0   EBITDA   1,555 841 -1,791 -68,911 -19,737 -7,704 0.0 0.0   EBIT   1,522 841 -1,791 -68,911 -19,737 -7,704 0.0 0.0   Pre-tax profit (PTP)   1,523.0 735.0 -2,152.0 -64,790.0 -25,550.0 -7,823.0 0.0 0.0   Net earnings   1,523.0 484.0 -2,152.0 -59,290.0 -25,549.0 -7,820.0 0.0 0.0   Pre-tax profit without non-rec. items   1,523 736 -2,152 -64,790 -25,550 -7,823 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   61.0 3,382 2,422 12,683 1,537 993 0.0 0.0   Shareholders equity total   5,542 3,026 13,872 274,482 10,113 15,831 15,857 15,857   Interest-bearing liabilities   0.0 0.0 489 697 329 118 0.0 0.0   Balance sheet total (assets)   9,213 14,090 32,477 330,238 18,535 23,601 15,857 15,857   Net Debt   -7,681 -8,394 -20,493 -207,953 -8,269 -11,420 -14,279 -14,279     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 18,575 53,577 131,533 23,652 26,486 26,486 26,486   Net sales growth   0.0% 0.0% 188.4% 145.5% -82.0% 12.0% 0.0% 0.0%   Gross profit   0.0 15,225 39,336 59,249 4,859 9,966 0.0 0.0   Gross profit growth   0.0% 0.0% 158.4% 50.6% -91.8% 105.1% -100.0% 0.0%   Employees   7 0 0 0 0 0 0 0   Employee growth %   133.3% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   9,213 14,090 32,477 330,238 18,535 23,601 15,857 15,857   Balance sheet change%   724.1% 52.9% 130.5% 916.8% -94.4% 27.3% -32.8% 0.0%   Added value   1,555.0 841.0 -1,791.0 -68,911.0 -19,737.0 -7,704.0 0.0 0.0   Added value %   0.0% 4.5% -3.3% -52.4% -83.4% -29.1% 0.0% 0.0%   Investments   -23 3,321 -960 10,261 -11,146 1,034 -993 0   Net sales trend   0.0 0.0 1.0 2.0 -1.0 1.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 4.5% -3.3% -52.4% -83.4% -29.1% 0.0% 0.0%   EBIT %   0.0% 4.5% -3.3% -52.4% -83.4% -29.1% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 5.5% -4.6% -116.3% -406.2% -77.3% 0.0% 0.0%   Net Earnings %   0.0% 2.6% -4.0% -45.1% -108.0% -29.5% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 2.6% -4.0% -45.1% -108.0% -29.5% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 4.0% -4.0% -49.3% -108.0% -29.5% 0.0% 0.0%   ROA %   29.5% 7.3% -6.8% -33.9% -14.5% -35.2% 0.0% 0.0%   ROI %   18.8% 7.6% -13.2% -38.0% -15.7% -44.6% 0.0% 0.0%   ROE %   51.6% 11.3% -25.5% -41.1% -18.0% -60.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   50.0% 21.5% 42.7% 83.1% 54.6% 67.1% 100.0% 100.0%   Relative indebtedness %   0.0% 59.6% 34.7% 42.4% 35.6% 29.3% 0.0% 0.0%   Relative net indebtedness %   0.0% 14.4% -4.4% -116.2% -0.7% -14.2% -53.9% -53.9%   Net int. bear. debt to EBITDA, %   -494.0% -998.1% 1,144.2% 301.8% 41.9% 148.2% 0.0% 0.0%   Gearing %   0.0% 0.0% 3.5% 0.3% 3.3% 0.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 229.9% 548.6% 36.6% 182.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   -1.7 1.3 1.6 8.6 2.3 2.8 0.0 0.0   Current Ratio   -1.7 1.3 1.6 8.6 2.3 2.8 0.0 0.0   Cash and cash equivalent   7,681.0 8,394.0 20,982.0 208,650.0 8,598.0 11,538.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 22.4 26.7 11.5 27.3 42.6 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 55.8% 55.0% 182.5% 55.6% 64.9% 53.9% 53.9%   Net working capital   14,694.0 2,345.0 11,002.0 212,085.0 7,540.0 10,994.0 0.0 0.0   Net working capital %   0.0% 12.6% 20.5% 161.2% 31.9% 41.5% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   222 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   222 0 0 0 0 0 0 0   EBIT / employee   217 0 0 0 0 0 0 0   Net earnings / employee   218 0 0 0 0 0 0 0